Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 391-393, 2002.
Article
in English
| WPRIM
| ID: wpr-302002
ABSTRACT
<p><b>OBJECTIVE</b>To study the effect of transcatheter arterial chemoembolization (TACE) combined with beta-ultrasound guided portal vein embolization (PVE) through fine-needle liver puncture for hepatocellular carcinoma.</p><p><b>METHODS</b>209 patients with primary hepatocellular carcinoma were divided into TACE group (104 patients) and TACE + PVE group (105 patients).</p><p><b>RESULTS</b>The response rates (CR + PR) were 37.5% in TACE group and 57.2% in TACE + PVE group (P < 0.01). Tumor thrombi became lessened or resolved in the portal vein with incidences of 22.2% in TACE group and 68.8% in TACE + PVE group (P < 0.01). The 1-, 2- and 3-year survival rates were 65.1%, 36.3% and 20.5% in TACE group and 95.6%, 59.6% and 39.1% in TACE + PVE group (P < 0.05).</p><p><b>CONCLUSION</b>The effect of TACE combined with PVE is much more effective than TACE alone for hepatocellular carcinoma. Beta-ultrasound guided portal vein embolization through fine-needle liver puncture is effective, easy, safe and should be widely practiced.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Portal Vein
/
Arteries
/
Therapeutics
/
Catheterization
/
Alpha-Fetoproteins
/
Follow-Up Studies
/
Treatment Outcome
/
Chemoembolization, Therapeutic
/
Carcinoma, Hepatocellular
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
Chinese Journal of Oncology
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS